WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering,...